Emmaus Life Sciences Receives Marketing Authorization for Endari® in Oman

/PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), a leader in sickle cell disease treatment, today announced that it has received marketing...

Related Keywords

France ,United Arab Emirates ,United States ,Woman ,Bahrain ,Saudi Arabia ,Netherlands ,Israel ,Qatar ,Kuwait ,Kingdom Of Saudi Arabia ,Omanis ,Omani ,Americans ,Yutaka Niihara ,Willis Lee ,George Sekulich ,Exchange Commission ,Emmaus Life Sciences Inc ,Oman Ministry Of Health ,Company Contact ,Centers For Disease ,Emmaus Life Sciences ,Global Commercialization Of Emmaus Life Sciences Inc ,National Center On Birth Defects ,Committee On Addressing Sickle Cell Disease ,Prnewswire Emmaus Life Sciences Inc ,Blueprint For Action National Academy Of Sciences ,Life Sciences ,Oman Ministry ,Chief Executive Officer ,Senior Vice President ,Global Commercialization ,Prescribing Information ,Sickle Cell Disease ,National Center ,Birth Defects ,Developmental Disabilities ,Disease Control ,Addressing Sickle Cell Disease ,Strategic Plan ,Sciences Press ,Private Securities Litigation Reform Act ,Nc ,Health Care Amp Hospitals ,Otc ,Mallcap ,Pharmaceuticals ,Medical Pharmaceuticals ,International Medical Approval ,